{"id":"https://openalex.org/W2010576366","doi":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","title":"Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine\u2010adriamycin\u2010dexamethasone (VAD) regimen","display_name":"Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine\u2010adriamycin\u2010dexamethasone (VAD) regimen","publication_year":1994,"publication_date":"1994-09-01","ids":{"openalex":"https://openalex.org/W2010576366","doi":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","mag":"2010576366","pmid":"https://pubmed.ncbi.nlm.nih.gov/7803263"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.1994.tb04982.x","doi":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Department of Hematology, M. D. Anderson Cancer Center, Houston, TX 77030","Dept. of Hematology, M.D. Anderson Cancer Center, Houston, TX 77030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, M. D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Dept. of Hematology, M.D. Anderson Cancer Center, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102743501","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0003-3386-6540","observed_orcids":["https://orcid.org/0000-0003-3386-6540"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan O'Brien","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Terry Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry Smith","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057920623","display_name":"Elihu H. Estey","orcid":"https://orcid.org/0000-0002-0987-8077","observed_orcids":["https://orcid.org/0000-0002-0987-8077"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elihu H. Estey","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098411155","display_name":"Miloslav Berran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miloslav Berran","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062466824","display_name":"A. Preti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Preti","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071687115","display_name":"Sherry A. Pierce","orcid":"https://orcid.org/0000-0001-6641-7659","observed_orcids":["https://orcid.org/0000-0001-6641-7659"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherry Pierce","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112181636","display_name":"Michael J. Keating","orcid":"https://orcid.org/0000-0002-9121-6450","observed_orcids":["https://orcid.org/0000-0002-9121-6450"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Keating","raw_affiliation_strings":["Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","University of Texas, M. D. Anderson Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Hematology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090435894"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":3.5921,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.92296238,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"88","issue":"1","first_page":"94","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vad-regimen","display_name":"VAD regimen","score":0.8989999890327454},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8149999976158142},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8730000257492065},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/induction-mortality","display_name":"induction mortality","score":0.5699999928474426},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8069999814033508},{"id":"https://openalex.org/keywords/growth-factors","display_name":"growth factors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9079525470733643},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.726818323135376},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.72353595495224},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6527683734893799},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.623216986656189},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6141429543495178},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4496321678161621},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.44942614436149597},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.41023725271224976},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3294026851654053},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.22456952929496765}],"mesh":[{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.1994.tb04982.x","doi":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1994.tb04982.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:7803263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7803263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1561285959","https://openalex.org/W1582130462","https://openalex.org/W1834314364","https://openalex.org/W1894115693","https://openalex.org/W1979300931","https://openalex.org/W2122962750","https://openalex.org/W2166782246","https://openalex.org/W2191423525","https://openalex.org/W2401219920","https://openalex.org/W2418545696","https://openalex.org/W2419558755","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W2279190990","https://openalex.org/W2070520252","https://openalex.org/W2553936756","https://openalex.org/W1989015491","https://openalex.org/W2036150210","https://openalex.org/W2007370979","https://openalex.org/W2408224728","https://openalex.org/W2548059309","https://openalex.org/W2007107048","https://openalex.org/W1834314364"],"abstract_inverted_index":{"To":[0],"analyse":[1],"the":[2,27,170,215,266,289],"pretreatment":[3],"characteristics,":[4,34],"response":[5,35,161,251],"to":[6,36,52,163,169,188,243,252],"therapy,":[7,38,127],"and":[8,39,50,99,105,113,150,196,232,283,298],"overall":[9,40,151,216],"prognosis":[10],"of":[11,84,117,291],"elderly":[12,67,128,179,210,256],"patients":[13,45,56,68,129,137,211,257],"with":[14,22,64,69,258,265,288],"acute":[15],"lymphocytic":[16],"leukaemia":[17],"(ALL),":[18],"268":[19],"consecutive":[20],"adults":[21],"newly-diagnosed":[23],"ALL":[24,70,180,259],"who":[25],"received":[26],"vincristine-adriamycin-dexamethasone":[28],"(VAD)":[29],"regimens":[30],"were":[31,42,58,226],"reviewed.":[32],"Pretreatment":[33],"VAD":[37,125,164,267],"outcome":[41],"analysed":[43],"in":[44,178,209,279,294],"60":[46,59],"years":[47,60],"or":[48,61],"older,":[49],"compared":[51],"younger":[53,65,136],"patients.":[54,181],"Fifty-two":[55],"(19%)":[57],"older.":[62],"Compared":[63],"patients,":[66],"had":[71,130],"a":[72,114,131],"significantly":[73],"worse":[74,108],"performance":[75],"status":[76],"at":[77,222],"presentation":[78],"(P":[79,88,92,96,102,110,121,193,200],"<":[80,93,97,148,158,201],"0.001);":[81],"higher":[82,115,190],"incidences":[83],"FAB":[85],"L2":[86],"morphology":[87],"=":[89,103,111,122,194],"0.03),":[90],"thrombocytopenia":[91],"0.01),":[94,149],"hypoalbuminaemia":[95],"0.001)":[98],"renal":[100],"dysfunction":[101],"0.03);":[104],"trends":[106],"for":[107,250],"anaemia":[109],"0.06)":[112],"rate":[116,134,143,162,185,206,264],"myeloid":[118],"markers":[119],"positivity":[120],"0.06).":[123],"With":[124],"induction":[126,140,191,282],"lower":[132,183],"CR":[133,172,184,205,263,271],"than":[135],"following":[138],"two":[139],"courses":[141],"(CR":[142,152],"58%":[144],"v":[145,155],"82%;":[146],"P":[147,157],"rates":[153,173],"65%":[154],"90%;":[156],"0.01).":[159,202],"The":[160,182,203,276],"chemotherapy,":[165],"however,":[166],"appeared":[167],"superior":[168],"30-35%":[171],"reported":[174],"from":[175],"other":[176,233],"series":[177],"was":[186,207,218],"due":[187],"both":[189,280,295],"mortality":[192,278],"0.02)":[195],"more":[197],"resistant":[198],"disease":[199],"long-term":[204],"20%":[208],"achieving":[212,270],"CR,":[213],"but":[214],"survival":[217],"poor":[219,234,247],"(<":[220],"10%":[221],"3":[223],"years).":[224],"There":[225],"strong":[227],"associations":[228],"between":[229],"older":[230,241],"age":[231,242],"prognostic":[235,248],"features.":[236],"However,":[237],"multivariate":[238],"analyses":[239],"identified":[240],"be":[244,286],"an":[245,261],"independent":[246],"factor":[249],"chemotherapy.":[253],"In":[254],"summary,":[255],"have":[260,273],"appreciable":[262],"regimens.":[268],"Patients":[269],"may":[272,285],"durable":[274],"remissions.":[275],"myelosuppression-associated":[277],"remission":[281],"maintenance":[284,302],"reduced":[287],"addition":[290],"growth":[292],"factors":[293],"treatment":[296],"phases,":[297],"by":[299],"using":[300],"standard":[301],"therapy":[303],"without":[304],"consolidation-intensification":[305],"phases.":[306]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}